A Double-blind, Placebo-controlled, Randomized, Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MDCO-2010 in Patients Undergoing Elective CABG Surgery

Trial Profile

A Double-blind, Placebo-controlled, Randomized, Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MDCO-2010 in Patients Undergoing Elective CABG Surgery

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Oct 2014

At a glance

  • Drugs MDCO 2010 (Primary)
  • Indications Thrombosis
  • Focus Adverse reactions
  • Sponsors The Medicines Company
  • Most Recent Events

    • 25 Oct 2011 New trial record
    • 19 Oct 2011 Results presented at the 2011 Annual Meeting of the American Society of Anesthesiologists.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top